Browsing by Author Concord Clinical School: Asbestos Disease Research Institute

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 23  next >
Issue DateTitleAuthor(s)Citation
2015Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9Cheng, Yuen Yee; Chan, Thomas; Chau, David; Fong, Bonnie; Kwong, Yok-Lam; Ng, Karen; Tam, Sidney; Tse, Eric; Concord Clinical School: Asbestos Disease Research InstituteAzacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9, Journal of Hematology & Oncology, vol.8, 1, 2015,pp 1-11
2018Bibliometric analysis of gaps in research on asbestos-related diseases: Declining emphasis on public health over 26 yearsDriscoll, Timothy; Lin, Ro-Ting; Soeberg, Matthew; Takahashi, Ken; Chien, Lung-Chang; Fisher, Scott; Lemen, Richard; Takala, Jukka; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research Institute; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research InstituteBibliometric analysis of gaps in research on asbestos-related diseases: Declining emphasis on public health over 26 years, BMJ Open, vol.8, 7, 2018,pp N/A-N/A
2018Bibliometric analysis of gaps in research on asbestos-related diseases: Declining emphasis on public health over 26 yearsDriscoll, Timothy; Lin, Ro-Ting; Soeberg, Matthew; Takahashi, Ken; Chien, Lung-Chang; Fisher, Scott; Lemen, Richard; Takala, Jukka; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research Institute; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research InstituteBibliometric analysis of gaps in research on asbestos-related diseases: Declining emphasis on public health over 26 years, BMJ Open, vol.8, 7, 2018,pp N/A-N/A
2018Bibliometric analysis of gaps in research on asbestos-related diseases: Declining emphasis on public health over 26 yearsDriscoll, Timothy; Lin, Ro-Ting; Soeberg, Matthew; Takahashi, Ken; Chien, Lung-Chang; Fisher, Scott; Lemen, Richard; Takala, Jukka; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research Institute; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research InstituteBibliometric analysis of gaps in research on asbestos-related diseases: Declining emphasis on public health over 26 years, BMJ Open, vol.8, 7, 2018,pp N/A-N/A
2014Cilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5Cheng, Ngan Ching; Reid, Glen; van Zandwijk, Nico; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteCilengitide Inhibits Attachment and Invasion of Malignant Pleural Mesothelioma Cells through Antagonism of Integrins αvβ3 and αvβ5, PLoS One, vol.9, 3, 2014,pp 1-10
2017Compensation for asbestos-related diseases in Japan: Utilization of standard classifications of industry and occupationsTakahashi, Ken; Chimed-Ochir, Odgerel; Furuya, Sugio; Myong, Jun-Pyo; Park, Eun-Kee; Ramos-Bonilla, Juan Pablo; Sawanyawisuth, Kittisak; Concord Clinical School: Asbestos Disease Research InstituteCompensation for asbestos-related diseases in Japan: Utilization of standard classifications of industry and occupations, Asian Pacific Journal of Cancer Prevention, vol.18, 7, 2017,pp 1779-1782
2017DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of CancerCheng, Yuen Yee; Leygo, Catherine; Williams, Marissa; Chan, Michael; Chu, Wai-Kit; Grusch, Michael; Jin, Hong Chuan; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research InstituteDNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer, Disease Markers, vol.2017, N/A, 2017,pp 1-13
2017Estimation of the global burden of mesothelioma deaths from incomplete national mortality dataDriscoll, Timothy; Takahashi, Ken; van Zandwijk, Nico; Fitzmaurice, Christina; Furuya, Sugio; Horie, Seichi; Odgerel, Chimed-Ochir; Sawanyawisuth, Kittisak; Sorahan, Tom; Takala, Jukka; Tanaka, Fumihiro; Yoko-o, Makoto; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: MedicineEstimation of the global burden of mesothelioma deaths from incomplete national mortality data, Occupational and Environmental Medicine, vol.74, 12, 2017,pp 851-858
2017Experience of Japan in achieving a total ban on asbestosTakahashi, Ken; Furuya, Sugio; Concord Clinical School: Asbestos Disease Research InstituteExperience of Japan in achieving a total ban on asbestos, International Journal of Environmental Research and Public Health, vol.14, 10, 2017,pp 1-10
2017Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016Driscoll, Timothy; Takahashi, Ken; Abajobir, Amanuel Alemu; Abbafati, Cristiana; Abbas, Kaja M; Abd-Allah, Foad; Abera, Semaw Ferede; Aboyans, Victor; Adetokunboh, Olatunji; Afshin, A; Agrawal, Anurag; Ahmadi, Alireza; Ahmed, Muktar Beshir; Aichour, Amani Nidhal; Aichour, Ibtihel; Aichour, Miloud Taki Eddine; Aiyar, S; Alahdab, Fares; Al-Eyadhy, Ayman; Arnlov, Johan; et al, Various; Kiadaliri, Aliasghar Ahmad; Naghavi, M; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research InstituteGlobal, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016, The Lancet, vol.390, 10100, 2017,pp 1151-1210
2017Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016Driscoll, Timothy; Leigh, James; Takahashi, Ken; Abajobir, Amanuel Alemu; Abate, Kalkidan Hassen; Abbafati, Cristiana; Abbas, Kaja M; Abd-Allah, Foad; Abdulle, Abdishakur M; Abera, Abdishakur M; Afshin, A; Alam, Kazi Mohammad Noore; Beardsley, Justin; et al, Various; Gakidou, Emmanuela; School of Public Health: Public Health; School of Public Health: Public Health; Concord Clinical School: Asbestos Disease Research InstituteGlobal, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016, The Lancet, vol.390, 10100, 2017,pp 1345-1422
2015Identification of dual PPARα/γ agonists and their effects on lipid metabolismBalaban, Seher; Cairns, Rose; Gao, Q; Grewal, Thomas; Groundwater, Paul; Hanh, Jacky; Hibbs, David; Hoy, Andrew; Lai, Felcia; Liao, Vivian; Lin, Hsuan-Yu Jennifer; Ong, Jennifer; Sjoestroem, Helena; Varadi, Linda; Wood, Peta; School of Medical Sciences: Physiology; School of Medical Sciences: Pharmacology; Pharmacy; Pharmacy; Pharmacy; Concord Clinical School: Asbestos Disease Research Institute; Pharmacy; School of Medical Sciences: Physiology; Pharmacy; Central Clinical School: Medicine; Pharmacy; Pharmacy; Pharmacy; Pharmacy; PharmacyIdentification of dual PPARα/γ agonists and their effects on lipid metabolism, Bioorganic and Medicinal Chemistry, vol.23, 24, 2015,pp 7676-7684
2016KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaCheng, Victoria Yuen Yee; Edelman, John (James); Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Williams, Marissa; Kirschner, Michaela B; Klebe, Sonja; Leshchynska, Iryna; Lin, Ruby C. Y.; McCaughan, Brian; Sarun, Kadir; Sytnyk, Vladimir; Wright, Casey; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research InstituteKCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma, Molecular Cancer, vol.15, 1, 2016,pp 1-12
2016KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaCheng, Victoria Yuen Yee; Edelman, John (James); Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Williams, Marissa; Kirschner, Michaela B; Klebe, Sonja; Leshchynska, Iryna; Lin, Ruby C. Y.; McCaughan, Brian; Sarun, Kadir; Sytnyk, Vladimir; Wright, Casey; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research InstituteKCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma, Molecular Cancer, vol.15, 1, 2016,pp 1-12
2015miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCooper, Wendy Anne; Edelman, John (James); Hanh, Jacky; Kao, Steven; Kirschner, Michaela; Linton, Anthony; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Amaro-Mugridge, Nancy; Brahmbhatt, Himanshu; Cheng, YuenYee; Klebe, Sonja; Lin, Ruby C. Y.; MacDiarmid, Jennifer; McCaughan, Brian; Weiss, Jocelyn; Williams, Marissa; Wright, Casey; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstitutemiR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma, Oncotarget, vol.6, 27, 2015,pp 23480-23495
2015MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesotheliomaArmstrong, Nicola Joy; Cheng, Yuen Yee; Kao, Steven; Kirschner, Michaela; Lin, Ruby; Linton, Anthony; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Klebe, Sonja; Mathematics & Statistics; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Molecular Bioscience; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteMiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma, Molecular Oncology, vol.9, N/A, 2015,pp 715-726
2013Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant MesotheliomaCheng, Yuen Yee; Reid, Glen; Baltic, Svetlana; Cheah, Hui Min; Klebe, Sonja; Lim, Chuan Bian; Mutsaers, Steven; Prele, Cecilia; Thompson, Philip J.; Watkins, D. Neil; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: MedicineMutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma, PLoS One, vol.8, 6, 2013,pp 1-12
2014An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesotheliomaCheng, Yuen Yee; Gattani, S; Kao, Steven; Kirschner, Michaela; Linton, Anthony; McCaughan, Brian; Reid, Glen; Srikaran, Subothini; van Zandwijk, Nico; Griggs, Kim; Klebe, Sonja; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: ANZAC Research InstituteAn RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma, British Journal of Cancer, vol.110, 2, 2014,pp 510-519
2017Role of hepatic Annexin A6 in fatty acid-induced lipid droplet formationCairns, Rose; Grewal, Thomas; Hanh, Jacky; Hosseini Beheshti, Elham; Hoy, Andrew; Nagarajan, Shilpa; Wason, S; Alvarez-Guaita, Anna; Buechler, Christa; Enrich, Carlos; Martínez-Saludes, Ines; Monastyrskaya, Katia; Rentero, Carles; School of Medical Sciences: Pharmacology; Pharmacy; Concord Clinical School: Asbestos Disease Research Institute; Physiology; School of Medical Sciences: Physiology; Physiology; PharmacyRole of hepatic Annexin A6 in fatty acid-induced lipid droplet formation, Experimental Cell Research, vol.358, 2, 2017,pp 397-410
2017SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural MesotheliomaCheng, Yuen Yee; Leygo, Catherine; Mok, Ellie; Reid, Glen; George, A. M.; McLaughlin, Chris; Tan, Sarah; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: MedicineSFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma, Disease Markers, vol.2017, N/A, 2017,pp 1-10